Devatis GmbH

Poland

All drugs from this manufacturer

  • CINACALCET DEVATIS

    This medicine is used in adults to treat secondary hyperparathyroidism in patients with severe renal disease requiring dialysis, to reduce elevated calcium levels in patients with parathyroid carcinoma or primary hyperparathyroidism (if surgery is not possible). In children and adolescents, it is used to treat secondary hyperparathyroidism associated with severe renal disease when other treatment methods are not effective.

    Dosage form: tablets, film-coated

    Active substance Dosage
    cinacalcet 30 mg

    ATC: H05BX01

  • This medicine is used in adults to treat secondary hyperparathyroidism in patients with severe kidney disease requiring dialysis, to reduce elevated calcium levels in patients with parathyroid carcinoma, or in primary hyperparathyroidism (when surgery is not possible). In children and adolescents, it is used to treat secondary hyperparathyroidism associated with severe kidney disease.

    Dosage form: tablets, film-coated

    Active substance Dosage
    cinacalcet 60 mg

    ATC: H05BX01

  • This medicine is used in adults to treat secondary hyperparathyroidism in patients with severe kidney disease requiring dialysis, and to reduce elevated calcium levels in patients with parathyroid carcinoma or primary hyperparathyroidism (if surgery is not possible). In children and adolescents, it is used to treat secondary hyperparathyroidism associated with severe kidney disease.

    Dosage form: tablets, film-coated

    Active substance Dosage
    cinacalcet 90 mg

    ATC: H05BX01